#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Co-opts the FGF2 Signaling Pathway to Enhance Infection


The molecular details of Chlamydia trachomatis binding, entry, and spread are incompletely understood, but heparan sulfate proteoglycans (HSPGs) play a role in the initial binding steps. As cell surface HSPGs facilitate the interactions of many growth factors with their receptors, we investigated the role of HSPG-dependent growth factors in C. trachomatis infection. Here, we report a novel finding that Fibroblast Growth Factor 2 (FGF2) is necessary and sufficient to enhance C. trachomatis binding to host cells in an HSPG-dependent manner. FGF2 binds directly to elementary bodies (EBs) where it may function as a bridging molecule to facilitate interactions of EBs with the FGF receptor (FGFR) on the cell surface. Upon EB binding, FGFR is activated locally and contributes to bacterial uptake into non-phagocytic cells. We further show that C. trachomatis infection stimulates fgf2 transcription and enhances production and release of FGF2 through a pathway that requires bacterial protein synthesis and activation of the Erk1/2 signaling pathway but that is independent of FGFR activation. Intracellular replication of the bacteria results in host proteosome-mediated degradation of the high molecular weight (HMW) isoforms of FGF2 and increased amounts of the low molecular weight (LMW) isoforms, which are released upon host cell death. Finally, we demonstrate the in vivo relevance of these findings by showing that conditioned medium from C. trachomatis infected cells is enriched for LMW FGF2, accounting for its ability to enhance C. trachomatis infectivity in additional rounds of infection. Together, these results demonstrate that C. trachomatis utilizes multiple mechanisms to co-opt the host cell FGF2 pathway to enhance bacterial infection and spread.


Vyšlo v časopise: Co-opts the FGF2 Signaling Pathway to Enhance Infection. PLoS Pathog 7(10): e32767. doi:10.1371/journal.ppat.1002285
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002285

Souhrn

The molecular details of Chlamydia trachomatis binding, entry, and spread are incompletely understood, but heparan sulfate proteoglycans (HSPGs) play a role in the initial binding steps. As cell surface HSPGs facilitate the interactions of many growth factors with their receptors, we investigated the role of HSPG-dependent growth factors in C. trachomatis infection. Here, we report a novel finding that Fibroblast Growth Factor 2 (FGF2) is necessary and sufficient to enhance C. trachomatis binding to host cells in an HSPG-dependent manner. FGF2 binds directly to elementary bodies (EBs) where it may function as a bridging molecule to facilitate interactions of EBs with the FGF receptor (FGFR) on the cell surface. Upon EB binding, FGFR is activated locally and contributes to bacterial uptake into non-phagocytic cells. We further show that C. trachomatis infection stimulates fgf2 transcription and enhances production and release of FGF2 through a pathway that requires bacterial protein synthesis and activation of the Erk1/2 signaling pathway but that is independent of FGFR activation. Intracellular replication of the bacteria results in host proteosome-mediated degradation of the high molecular weight (HMW) isoforms of FGF2 and increased amounts of the low molecular weight (LMW) isoforms, which are released upon host cell death. Finally, we demonstrate the in vivo relevance of these findings by showing that conditioned medium from C. trachomatis infected cells is enriched for LMW FGF2, accounting for its ability to enhance C. trachomatis infectivity in additional rounds of infection. Together, these results demonstrate that C. trachomatis utilizes multiple mechanisms to co-opt the host cell FGF2 pathway to enhance bacterial infection and spread.


Zdroje

1. MandellGLBennettJEDolinR 2010 Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 7th ed. Philadelphia, PA Churchill Livingstone/Elsevier pp. 1 online resource (2 v. (cl, 4028, xcvii p.))

2. MoulderJW 1991 Interaction of chlamydiae and host cells in vitro. Microbiol Rev 55 143 190

3. Dautry-VarsatASubtilAHackstadtT 2005 Recent insights into the mechanisms of Chlamydia entry. Cell Microbiol 7 1714 1722

4. CocchiaroJLValdiviaRH 2009 New insights into Chlamydia intracellular survival mechanisms. Cell Microbiol 11 1571 1578

5. ElwellCACeesayAKimJHKalmanDEngelJN 2008 RNA interference screen identifies Abl kinase and PDGFR signaling in Chlamydia trachomatis entry. PLoS Pathog 4 e1000021

6. CliftonDRFieldsKAGrieshaberSSDooleyCAFischerER 2004 A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. Proc Natl Acad Sci U S A 101 10166 10171

7. JewettTJMillerNJDooleyCAHackstadtT 2010 The conserved Tarp actin binding domain is important for chlamydial invasion. PLoS Pathog 6 e1000997

8. HackstadtT 2000 Redirection of host vesicle trafficking pathways by intracellular parasites. Traffic 1 93 99

9. HybiskeKStephensRS 2007 Mechanisms of host cell exit by the intracellular bacterium Chlamydia. Proc Natl Acad Sci U S A 104 11430 11435

10. XiaMBumgarnerRELampeMFStammWE 2003 Chlamydia trachomatis infection alters host cell transcription in diverse cellular pathways. J Infect Dis 187 424 434

11. FukudaEYLadSPMikolonDPIacobelli-MartinezMLiE 2005 Activation of lipid metabolism contributes to interleukin-8 production during Chlamydia trachomatis infection of cervical epithelial cells. Infect Immun 73 4017 4024

12. HvidMBaczynskaADeleuranBFedderJKnudsenHJ 2007 Interleukin-1 is the initiator of Fallopian tube destruction during Chlamydia trachomatis infection. Cell Microbiol 9 2795 2803

13. ChenJCZhangJPStephensRS 1996 Structural requirements of heparin binding to Chlamydia trachomatis. J Biol Chem 271 11134 11140

14. ChenJCStephensRS 1994 Trachoma and LGV biovars of Chlamydia trachomatis share the same glycosaminoglycan-dependent mechanism for infection of eukaryotic cells. Mol Microbiol 11 501 507

15. ChenJCStephensRS 1997 Chlamydia trachomatis glycosaminoglycan-dependent and independent attachment to eukaryotic cells. Microb Pathog 22 23 30

16. EskoJDLindahlU 2001 Molecular diversity of heparan sulfate. J Clin Invest 108 169 173

17. BishopJRSchukszMEskoJD 2007 Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446 1030

18. YuPJFerrariGGallowayACMignattiPPintucciG 2007 Basic fibroblast growth factor (FGF-2): the high molecular weight forms come of age. J Cell Biochem 100 1100 1108

19. KlagsbrunMSmithSSullivanRShingYDavidsonS 1987 Multiple forms of basic fibroblast growth factor: amino-terminal cleavages by tumor cell- and brain cell-derived acid proteinases. Proc Natl Acad Sci U S A 84 1839 1843

20. SchaferTZentgrafHZeheCBruggerBBernhagenJ 2004 Unconventional secretion of fibroblast growth factor 2 is mediated by direct translocation across the plasma membrane of mammalian cells. J Biol Chem 279 6244 6251

21. TemmermanKEbertADMullerHMSinningITewsI 2008 A direct role for phosphatidylinositol-4,5-bisphosphate in unconventional secretion of fibroblast growth factor 2. Traffic 9 1204 1217

22. PaderaRVenkataramanGBerryDGodavartiRSasisekharanR 1999 FGF-2/fibroblast growth factor receptor/heparin-like glycosaminoglycan interactions: a compensation model for FGF-2 signaling. FASEB J 13 1677 1687

23. RoghanMMansukhaniADell'EraPBellostaPBasilicoC 1994 Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. J Biol Chem 269 3976 3984

24. Spivack-KroizmanTLemmonMADikicILadburyJEPinchasiD 1994 Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell 79 1015 1024

25. ZhangYMcKeehanKLinYZhangJWangF 2008 Fibroblast growth factor receptor 1 (FGFR1) tyrosine phosphorylation regulates binding of FGFR substrate 2alpha (FRS2alpha) but not FRS2 to the receptor. Mol Endocrinol 22 167 175

26. GotohN 2008 Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins. Cancer Sci 99 1319 1325

27. TaraktchoglouMPaceyAATurnbullJEEleyA 2001 Infectivity of Chlamydia trachomatis serovar LGV but not E is dependent on host cell heparan sulfate. Infect Immun 69 968 976

28. BerryDKwanCPShriverZVenkataramanGSasisekharanR 2001 Distinct heparan sulfate glycosaminoglycans are responsible for mediating fibroblast growth factor-2 biological activity through different fibroblast growth factor receptors. FASEB J 15 1422 1424

29. SaxenaKSchieborrUAnderkaODuchardt-FernerEElshorstB 2010 Influence of heparin mimetics on the assembly of the FGF - FGFR4 signaling complex. J Biol Chem 285 26628 26640

30. KanMWuXWangFMcKeehanWL 1999 Specificity for fibroblast growth factors determined by heparan sulfate in a binary complex with the receptor kinase. J Biol Chem 274 15947 15952

31. ChenPYSimonsMFrieselR 2009 FRS2 via fibroblast growth factor receptor 1 is required for platelet-derived growth factor receptor beta-mediated regulation of vascular smooth muscle marker gene expression. J Biol Chem 284 15980 15992

32. RodelJWoytasMGrohASchmidtKHHartmannM 2000 Production of basic fibroblast growth factor and interleukin 6 by human smooth muscle cells following infection with Chlamydia pneumoniae. Infect Immun 68 3635 3641

33. ProchnauDRodelJHartmannMStraubeEFigullaHR 2004 Growth factor production in human endothelial cells after Chlamydia pneumoniae infection. Int J Med Microbiol 294 53 57

34. VlotidesGChenYHEiglerTRenSGMelmedS 2009 Fibroblast growth factor-2 autofeedback regulation in pituitary folliculostellate TtT/GF cells. Endocrinology 150 3252 3258

35. BaeYHBaeMKKimSRLeeJHWeeHJ 2009 Upregulation of fibroblast growth factor-2 by visfatin that promotes endothelial angiogenesis. Biochem Biophys Res Commun 379 206 211

36. SuHMcClartyGDongFHatchGMPanZK 2004 Activation of Raf/MEK/ERK/cPLA2 signaling pathway is essential for chlamydial acquisition of host glycerophospholipids. J Biol Chem 279 9409 9416

37. CoombesBKMahonyJB 2002 Identification of MEK- and phosphoinositide 3-kinase-dependent signalling as essential events during Chlamydia pneumoniae invasion of HEp2 cells. Cell Microbiol 4 447 460

38. BuchholzKRStephensRS 2007 The extracellular signal-regulated kinase/mitogen-activated protein kinase pathway induces the inflammatory factor interleukin-8 following Chlamydia trachomatis infection. Infect Immun 75 5924 5929

39. BuchholzKRStephensRS 2008 The cytosolic pattern recognition receptor NOD1 induces inflammatory interleukin-8 during Chlamydia trachomatis infection. Infect Immun 76 3150 3155

40. VignolaMJKashatusDFTaylorGACounterCMValdiviaRH 2010 cPLA2 regulates the expression of type I interferons and intracellular immunity to Chlamydia trachomatis. J Biol Chem 285 21625 21635

41. GurumurthyRKMaurerAPMachuyNHessSPleissnerKP 2010 A loss-of-function screen reveals Ras- and Raf-independent MEK-ERK signaling during Chlamydia trachomatis infection. Sci Signal 3 ra21

42. MehlitzABanhartSMaurerAPKaushanskyAGordusAG 2010 Tarp regulates early Chlamydia-induced host cell survival through interactions with the human adaptor protein SHC1. J Cell Biol 190 143 157

43. ConteCRiantEToutainCPujolFArnalJF 2008 FGF2 translationally induced by hypoxia is involved in negative and positive feedback loops with HIF-1alpha. PLoS One 3 e3078

44. GalyBCreancierLPrado-LourencoLPratsACPratsH 2001 p53 directs conformational change and translation initiation blockade of human fibroblast growth factor 2 mRNA. Oncogene 20 4613 4620

45. GalyBCreancierLZanibellatoCPratsACPratsH 2001 Tumour suppressor p53 inhibits human fibroblast growth factor 2 expression by a post-transcriptional mechanism. Oncogene 20 1669 1677

46. YuanLSantiMRushingEJCornelisonRMacDonaldTJ 2010 ERK activation of p21 activated kinase-1 (Pak1) is critical for medulloblastoma cell migration. Clin Exp Metastasis 27 481 491

47. TangWWeiYLeKLiZBaoY 2011 Mitogen-activated protein kinases ERK 1/2- and p38-GATA4 pathways mediate the Ang II-induced activation of FGF2 gene in neonatal rat cardiomyocytes. Biochem Pharmacol 81 518 525

48. LefevreGBabchiaNCalipelAMouriauxFFaussatAM 2009 Activation of the FGF2/FGFR1 autocrine loop for cell proliferation and survival in uveal melanoma cells. Invest Ophthalmol Vis Sci 50 1047 1057

49. ZhongGFanPJiHDongFHuangY 2001 Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J Exp Med 193 935 942

50. KumarYValdiviaRH 2008 Actin and intermediate filaments stabilize the Chlamydia trachomatis vacuole by forming dynamic structural scaffolds. Cell Host Microbe 4 159 169

51. FlorkiewiczRZMajackRABuechlerRDFlorkiewiczE 1995 Quantitative export of FGF-2 occurs through an alternative, energy-dependent, non-ER/Golgi pathway. J Cell Physiol 162 388 399

52. MignattiPMorimotoTRifkinDB 1992 Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J Cell Physiol 151 81 93

53. KellerMRueggAWernerSBeerHD 2008 Active caspase-1 is a regulator of unconventional protein secretion. Cell 132 818 831

54. DahlJPBindaACanfieldVALevensonR 2000 Participation of Na,K-ATPase in FGF-2 secretion: rescue of ouabain-inhibitable FGF-2 secretion by ouabain-resistant Na,K-ATPase alpha subunits. Biochemistry 39 14877 14883

55. TavernaSGhersiGGinestraARigogliusoSPecorellaS 2003 Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells. J Biol Chem 278 51911 51919

56. LuHShenCBrunhamRC 2000 Chlamydia trachomatis infection of epithelial cells induces the activation of caspase-1 and release of mature IL-18. J Immunol 165 1463 1469

57. DavisCHWyrickPB 1997 Differences in the association of Chlamydia trachomatis serovar E and serovar L2 with epithelial cells in vitro may reflect biological differences in vivo. Infect Immun 65 2914 2924

58. FadelSEleyA 2004 Chlorate: a reversible inhibitor of proteoglycan sulphation in Chlamydia trachomatis-infected cells. J Med Microbiol 53 93 95

59. MoellekenKHegemannJH 2008 The Chlamydia outer membrane protein OmcB is required for adhesion and exhibits biovar-specific differences in glycosaminoglycan binding. Mol Microbiol 67 403 419

60. EswarakumarVPLaxISchlessingerJ 2005 Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16 139 149

61. HashimotoAKurosakiMGotohNShibuyaMKurosakiT 1999 Shc regulates epidermal growth factor-induced activation of the JNK signaling pathway. J Biol Chem 274 20139 20143

62. KlintPKandaSClaesson-WelshL 1995 Shc and a novel 89-kDa component couple to the Grb2-Sos complex in fibroblast growth factor-2-stimulated cells. J Biol Chem 270 23337 23344

63. AloyPRussellRB 2006 Structural systems biology: modelling protein interactions. Nat Rev Mol Cell Biol 7 188 197

64. YuPJFerrariGPirelliLGallowayACMignattiP 2008 Thrombin cleaves the high molecular weight forms of basic fibroblast growth factor (FGF-2): a novel mechanism for the control of FGF-2 and thrombin activity. Oncogene 27 2594 2601

65. LofmarkSde KlerkNAroH 2011 Neisseria gonorrhoeae infection induces altered amphiregulin processing and release. PLoS One 6 e16369

66. DicksonJHGrabowskaAEl-ZaatariMAthertonJWatsonSA 2006 Helicobacter pylori can induce heparin-binding epidermal growth factor expression via gastrin and its receptor. Cancer Res 66 7524 7531

67. CoombesBKChiuBFongIWMahonyJB 2002 Chlamydia pneumoniae infection of endothelial cells induces transcriptional activation of platelet-derived growth factor-B: a potential link to intimal thickening in a rabbit model of atherosclerosis. J Infect Dis 185 1621 1630

68. ZittermannSIIssekutzAC 2006 Basic fibroblast growth factor (bFGF, FGF-2) potentiates leukocyte recruitment to inflammation by enhancing endothelial adhesion molecule expression. Am J Pathol 168 835 846

69. SorensenVNilsenTWiedlochaA 2006 Functional diversity of FGF-2 isoforms by intracellular sorting. Bioessays 28 504 514

70. PardoOEWellbrockCKhanzadaUKAubertMArozarenaI 2006 FGF-2 protects small cell lung cancer cells from apoptosis through a complex involving PKCepsilon, B-Raf and S6K2. EMBO J 25 3078 3088

71. van OoijCApodacaGEngelJ 1997 Characterization of the Chlamydia trachomatis vacuole and its interaction with the host endocytic pathway in HeLa cells. Infect Immun 65 758 766

72. CaldwellHDKromhoutJSchachterJ 1981 Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun 31 1161 1176

73. WinerJJungCKShackelIWilliamsPM 1999 Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270 41 49

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2011 Číslo 10
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#